Bio-Path Holdings (BPTH) Misses Q3 EPS by 3c

Bio-Path Holdings (NASDAQ: BPTH) reported Q3 EPS of ($0.49), $0.03 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
• BIG3 Basketball to go public via Graf Global merger at $290 million